Find Nonprofit and Small Business Grants

Advance Search

Only Available for Paid Subscribers
Clear Filters
Search Filters

Grants to USA Organizations to Address Inequities in Healthcare

Quality Improvement Grant - Quality Improvement Initiatives to Address Healthcare Barriers for Cardiac Amyloidosis

GrantWatch ID# 207906

Funding Source
National Medical Association (NMA) and Pfizer Global Medical Grants (GMG)
Array ( )

Geographic Focus

Important Dates
Deadline: 02/16/23 Save

Grant Description
Grants of up to $50,000 to USA organizations to address inequities in healthcare. The purpose of the program is to identify factors that exacerbate racial healthcare disparities and address social determinants of health in populations affected by Cardiac Amyloidosis. Collaborative partnerships with local organizations are encouraged.

This Request for Proposals (RFP) is for initiatives that span multiple rare disease areas. The National Medical Assocation (NMA) and Pfizer Global Medical Grants (GMG) are collaborating to offer a new competitive grant opportunity focused on supporting Quality Improvement projects which address significant barriers that contribute to geographic and racial healthcare disparities disproportionately impacting minority populations potentially affected by Cardiac Amyloidosis.

It is Pfizer's intent to support independent Quality Improvement (QI) initiatives which focus on one or both of the following:

  • Identify significant barriers that contribute to geographic and racial healthcare disparities disproportionately impacting minority populations potentially affected by Cardiac Amyloidosis (inclusive of hereditary transthyretin amyloid cardiomyopathy) and addressing these challenges to increase earlier diagnosis, quality care and improved patient outcomes through innovative and sustainable approaches.


  • Improve and help advance already established coordinated partnerships with local organizations (e.g., religious groups, local businesses) and local community healthcare centers to better address at least one social determinant of health (SDoH) and signs and symptoms of potential cardiac amyloidosis.

All projects ultimately supported must have a focus on data collection and analysis, specifically how the changes and improvements will be measured. The measurements should be tailored to the individual project and the specific data collection capabilities of the grantee.

Proposals coming from community engaged programs such as academic community partnerships and local community organizations (barber shops, beauty salons, religious groups, non-profit organizations, etc.) are encouraged and will be prioritized.


Additional Eligibility Criteria
• Only organizations are eligible to receive grants, not individuals or medical practice groups.
• Collaborations within institutions (e.g., between departments and/or interprofessional), as well as between different institutions / organizations / associations, are encouraged. Please note all partners must have a relevant role and the requesting organization must have a key role in the project.

For programs offering education credit, the requesting organization must be the accredited grantee.

It is not Pfizer's intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered. Projects that involve the creation or support of a patient registry are also not eligible.

Pre-Application Information
• RFP release date: December 22, 2022
• Full Proposal Deadline: February 16, 2023
• Review of Full Proposals by External Review Panel: March 2023
• Anticipated Full Proposal Notification Date: April 2023
• Grants distributed following execution of fully signed Letter of Agreement
• Anticipated Project Start a Date: May 2023

Additional Funding Information

Estimated Total Program Funding:


Estimated Size of Grant
Selected individual projects requesting up to $50,000 will be considered.

Contact Information
Apply online:

If you have questions regarding this RFP, please direct them in writing to the Grant Officer, Amanda Stein (, with the subject line “2023 RD US - NMA SDoH Cardiac Amyloidosis.”

Grant Writers For Hire - Grant Writer Team Grant News Grant Writers For Hire - Grant Writer Team
Live Chat Chat Now